Treatment or prevention of skin conditions or tissue conditions in animals using boryloxypyridylmethanones

Details for Australian Patent Application No. 2005254095 (hide)

Owner Anacor Pharmaceuticals, Inc.

Inventors Maples, Kirk R.; Bellinger-Kawahara, Carolyn; Perry, David

Agent Allens Arthur Robinson

Pub. Number AU-B-2005254095

PCT Pub. Number WO2005/123094

Priority 60/579,421 14.06.04 US

Filing date 14 June 2005

Wipo publication date 29 December 2005

Acceptance publication date 3 June 2010

International Classifications

A61K 31/69 (2006.01) - Boron compounds

A61P 17/00 (2006.01) Drugs for dermatological disorders

C07F 5/02 (2006.01) Compounds containing elements of the 3rd Group of the Periodic System

Event Publications

11 January 2007 PCT application entered the National Phase

  PCT publication WO2005/123094 Priority application(s): WO2005/123094

3 June 2010 Application Accepted

  Published as AU-B-2005254095

30 September 2010 Standard Patent Sealed

19 January 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005254096-Methods of using albuterol and calcium activated potassium channel openers

2005254092-Air bath with bypass vent